Contents

Search


Prevention of Syncope Trial (POST)

Randomized, placebo-controlled study for patients with vasovagal syncope. Treatment: - metoprolol 25-200 mg daily vs placebo Results: - metoprolol of no benefit

Related

fondaparinux (Arixtra)

General

clinical trial

References

Sheldon R et al, Prevention of Syncope Trial (POST): A randomized, placebo- controlled study of metoprolol in the prevention of vasovagal syncope Circulation 2006; 113:1164 PMID: 16505178